Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Imago BioSciences, Inc. (Nasdaq: IMGO), at a purchase price of $36.00 per share in cash, without ...

Related Keywords

United States ,Canada , ,Instagram ,Linkedin ,Twitter ,Imago Biosciences Inc ,Nasdaq ,Statement Of Merck Co Inc ,Exchange Commission ,Merck Co Inc ,Youtube ,Facebook ,Imago Biosciences ,Eastern Time ,Nasdaq Global ,Looking Statement ,Securities Litigation Reform Act ,Annual Report ,